AD, Leeds JS, Roberts KJ, McGeeney L, Duggan SN, Kumar R. Consensus for the management of pancreatic exocrine insufficiency: UK practical guidelines. BMJ Open Gastroenterol. 2021 Jun;8(1) \[[PMC free article: PMC8212181](/pmc/articles/PMC8212181/)\] \[[PubMed: 34140324](https://pubmed.ncbi.nlm.nih.gov/34140324)\] 39. Murruste M, Kirsimägi Ü, Kase K, Saar S, Talving P. Long-term survival, risk factors and causes of mortality in surgically treated chronic pancreatitis. Pancreatology. 2021 Jun;21(4):714-723. \[[PubMed: 33727036](https://pubmed.ncbi.nlm.nih.gov/33727036)\] 40. Olesen SS, Krauss T, Demir IE, Wilder-Smith OH, Ceyhan GO, Pasricha PJ, Drewes AM. Towards a neurobiological understanding of pain in chronic pancreatitis: mechanisms and implications for treatment. Pain Rep. 2017 Nov;2(6):e625. \[[PMC free article: PMC5741325](/pmc/articles/PMC5741325/)\] \[[PubMed: 29392239](https://pubmed.ncbi.nlm.nih.gov/29392239)\] 41. Shabanzadeh DM, Novovic S. Alcohol, smoking and benign hepato-biliary disease. Best Pract Res Clin Gastroenterol. 2017 Oct;31(5):519-527. \[[PubMed: 29195671](https://pubmed.ncbi.nlm.nih.gov/29195671)\] 42. Hintaran AD, Chenault MN, Verhaegh BPM, Reijven PLM, Masclee AAM, Keulemans YCA. Improving nutritional status assessment in patients with chronic pancreatitis. Pancreatology. 2018 Oct;18(7):785-791. \[[PubMed: 30064905](https://pubmed.ncbi.nlm.nih.gov/30064905)\] **Disclosure:** Eric Goosenberg declares no relevant financial relationships with ineligible companies. **Disclosure:** Sarah Lappin declares no relevant financial relationships with ineligible companies.